Search Results - "Nkunku, S"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis by Blum, J., Nkunku, S., Burri, C.

    Published in Tropical medicine & international health (01-05-2001)
    “…Encephalopathies are the most feared complications of sleeping sickness treatment with melarsoprol. To investigate the existence of risk factors, the incidence…”
    Get full text
    Journal Article
  2. 2

    Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness by Schmid, C, Nkunku, S, Merolle, A, Vounatsou, P, Burri, C

    Published in The Lancet (British edition) (28-08-2004)
    “…In 2000, we reported that a new short treatment schedule of melarsoprol was not worse than the longer and demanding standard treatment for late-stage human…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial by Burri, C, Nkunku, S, Merolle, A, Smith, T, Blum, J, Brun, R

    Published in The Lancet (British edition) (22-04-2000)
    “…African trypanosomiasis is a fatal disease caused by protozoan parasites of the species Trypanosoma brucei. The disease has reached epidemic dimensions in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial by Burri, C, Nkunku, S, Merolle, A, Smith, T, Blum, J, Brun, R

    Published in The Lancet (North American edition) (22-04-2000)
    “…African trypanosomiasis is a fatal disease caused by protozoan parasites of the species Trypanosoma brucei. The disease has reached epidemic dimensions in…”
    Get full text
    Journal Article